Trials / Completed
CompletedNCT04029766
A Study Evaluating Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of HSK3486 Single Bolus Dose Followed With a 30 Minute Constant Infusion in Healthy Male Subjects
A Phase 1 Study to Investigate a Single Bolus Dose Followed With a 30 Minute Constant Infusion of HSK3486 on the Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of HSK3486 in Healthy Male Subjects.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- Sichuan Haisco Pharmaceutical Group Co., Ltd · Industry
- Sex
- Male
- Age
- 18 Years – 49 Years
- Healthy volunteers
- Accepted
Summary
This study was a single center, open-label, single dose escalation study in healthy male subjects to investigate a bolus dose followed by a 30 minute constant infusion of HSK3486 over two cohorts.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HSK3486 |
Timeline
- Start date
- 2015-11-10
- Primary completion
- 2015-12-14
- Completion
- 2016-06-09
- First posted
- 2019-07-23
- Last updated
- 2021-01-29
Source: ClinicalTrials.gov record NCT04029766. Inclusion in this directory is not an endorsement.